Username Password
S&P 500: 1,351.68 Change: +0.14%

PDL BIOPHARMA INC (PDLI)

Overview
Price 6.49
Price Change Today 0.00 (0.00%)
P&P rating Rating: 4
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $6.49
Daily Range $0.00 - $0.00
52-Week Range $4.66 - $6.70
Volume 0
chart
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Other Resources for PDLI
zacks.com
Commentary
Zacks Blog: Don't Get Trapped by High Dividends
December 12, 2011
Zacks Blog: PDLI Beats by a Penny on Lower Costs
November 10, 2011
Zacks Blog: PDL BioPharma Guides Q3 Sales
September 12, 2011
Zacks Blog: PDLI Lags on Lower Avastin Royalty
August 1, 2011
Zacks Blog: Favorable Court Ruling for PDLI
July 12, 2011
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
 
Brokerage Analyst Recommendations
5 Brokerage Firms Covering PDLI
 
  
Strong Buy
1
Buy
0
Hold
4
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 2.6
 
PDLI Ratings:BUY  SELL  HOLD
PDLI Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

34 Buy
0 Sell
 
Top Buy Analysis
BUY: PDLI Rating: 4
Company: PDL BIOPHARMA INC.
Points: -9.24
Start Price: $6.05
Start Date: 11/23/2011 9:02 PM
ELiaw
ELiaw
P&P Score: 97.97
Recs:
Crossed over MA(200)

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Vet67to82
95.96 07/27/10 Special Dividends 4 08/16/10
Vet67to82
95.96 04/27/10 AlphaDog Stocks 7 05/19/10
Vet67to82
95.96 04/27/10 Data Mining - with your OWN spreadsheets 1 05/07/10
zantriocom
0.00 12/02/09 Zantrio.com Free Daily Stock Picks 12-2-09 0
zantriocom
0.00 07/31/09 Zantrio.com Stock Picks for July 31, 2009 0
Zacks_Analysts
0.00 12/12/11 Don't Get Trapped by High Dividends - Analyst Blog 0
Zacks_Analysts
0.00 11/10/11 PDLI Beats by a Penny on Lower Costs - Analyst Blog 0
Zacks_Analysts
0.00 09/12/11 PDL BioPharma Guides Q3 Sales - Analyst Blog 0
Zacks_Analysts
0.00 07/12/11 Favorable Court Ruling for PDLI - Analyst Blog 0
Zacks_Analysts
0.00 06/02/11 PDLI Guides Q2 Revenues of $128M - Analyst Blog 0
Pages: [ 1 ]  2   3  >>
Commentary
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $6.05
Points: -9.24
Created: 11/23/2011
Crossed over MA(200)

Comments: 0 | Comment

Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $5.67
Points: -14.53
Created: 08/31/2010
Ended pick due to disappointing performance, even though PDLI has outperformed the market ... thought it would respond better to the dividend ... then PDLI got a fascimile questioning it's EU patents that I do not believe will impact revenue.

Comments: 11 | Comment

Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $8.42
Points: -49.51
Created: 09/16/2009
Great dividend for the price. Rumors of being bought. I had an another stock that went from $6 to $18 because it was bought. I hope to do the same here.

Comments: 0 | Comment

Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $12.44
Points: -53.96
Created: 08/20/2008

Comments: 0 | Comment

Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $5.35
Points: -1.84
Created: 10/15/2011

Comments: 0 | Comment

vip vip
Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $7.16
Points: -52.92
Created: 06/04/2009

Comments: 0 | Comment

Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $6.30
Points: -42.88
Created: 01/05/2009

Comments: 0 | Comment

Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $7.90
Points: -55.21
Created: 10/08/2008

Comments: 0 | Comment

Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $9.31
Points: -46.29
Created: 09/30/2008

Comments: 0 | Comment

Recs:
 
BUY: PDL BIOPHARMA INC. (PDLI) Rating: 4
Start Price: $12.07
Points: -51.68
Created: 08/29/2008

Comments: 0 | Comment

KAP KAP
Recs:
 
Pages: [ 1 ]  2   3   4  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
ELiaw 97.97 BUY Three Plus Years 11/23/2011 $6.05 $6.48
(-0.08%)
+7.11% +16.34% -9.24 view
vip 99.98 BUY One to Three Months 10/15/2011 $5.35 $6.48
(-0.08%)
+21.12% +22.97% -1.84
Vet67to82 95.96 BUY Week to a Month 08/31/2010 $5.67 $6.48
(-0.08%)
+14.29% +28.81% -14.53 view
yourtxlady 57.92 BUY Week or Less 09/16/2009 $8.42 $6.48
(-0.08%)
-23.04% +26.47% -49.51 view
george.ray 3.13 BUY One to Three Months 06/04/2009 $7.16 $6.48
(-0.08%)
-9.50% +43.42% -52.92
LeveneOMurray 0.45 BUY Week or Less 01/05/2009 $6.30 $6.48
(-0.08%)
+2.86% +45.74% -42.88
OpeningBell 43.35 BUY Three to Six Months 10/08/2008 $7.90 $6.48
(-0.08%)
-17.97% +37.23% -55.21
RazorBurn 28.83 BUY Six Months to a Year 09/30/2008 $9.31 $6.48
(-0.08%)
-30.40% +15.89% -46.29
KAP 3.58 BUY One to Three Years 08/29/2008 $12.07 $6.48
(-0.08%)
-46.31% +5.37% -51.68
monish 75.80 BUY Week or Less 08/28/2008 $12.07 $6.48
(-0.08%)
-46.31% +3.92% -50.23
Pages: [ 1 ]  2   3   4  >>
Sponsored Links